US 11571444
Enhancement of MSC immunomodulatory properties by treprostinil
granted A61KA61K31/192A61K35/28
Quick answer
US patent 11571444 (Enhancement of MSC immunomodulatory properties by treprostinil) held by United Therapeutics Corporation expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/192, A61K35/28, A61P, A61P11/00